DTIL earnings date and last-quarter result: next report 2026-08-06, last quarter beat, P/E -2.00. Updated 2026-07-23.
Precision BioSciences (DTIL) Research Hub
Precision BioSciences (DTIL) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 6.41 USD (-3.46%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -2.00, market cap 0.09B. This hub links to the full technical, earnings and options research available for DTIL.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 6.41 USD (-3.46%) |
| 52-week range | 5.72 USD – 9.62 USD |
| Trend regime | Range |
| 14-day RSI | 53.4 (Neutral) |
| Trailing P/E | -2.00 |
| Market cap | 0.09B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-06 |
Available research for DTIL
Covered Call on DTIL: how it works, illustrative setup around the real 6.41 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on DTIL: how it works, illustrative setup around the real 6.41 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on DTIL: how it works, illustrative setup around the real 6.41 USD price, max profit/loss, breakeven and when to use it. Educational.
DTIL technical analysis: range, last 6.41 USD, RSI 53.4, 52w range 5.72 USD–9.62 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is DTIL in?
Precision BioSciences (DTIL) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is DTIL in an uptrend or downtrend?
As of 2026-10-26, DTIL is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is DTIL's trailing P/E ratio?
DTIL's trailing P/E is -2.00, with a market cap of 0.09B. See the earnings research page for full valuation detail.
When does DTIL next report earnings?
DTIL is next scheduled to report earnings on 2026-08-06.